nei THIS MONTH IN
PSYCHOPHARMACOLOGY
FDA Gives Clearance To Neuromodulation System for Treatment of Severe Depression
September 12, 2022   

Image

Magnus Medical recently received U.S. Food and Drug Administration (FDA) approval for its neuromodulation system used to treat major depressive disorder (MDD). The 510(k) clearance is for the non-invasive, individualized treatment for patients who did not improve from prior antidepressant medications in the current episode, and follows the breakthrough device designation granted by the FDA to the neurostimulation technology in October 2021. The results of a double-blinded randomized controlled trial (RCT) that assessed the SAINT Neuromodulation System were published in the American Journal of Psychiatry. The trial demonstrated that 79% of those receiving active treatment had achieved remission from their depressive symptoms when compared to 13% in the sham treatment arm. This neuromodulation system uses structural and functional magnetic resonance imaging (fMRI) to inform a proprietary algorithm that identifies the optimal anatomic target for focused neurostimulation in people with MDD. According to the medical device company, this approach is delivered on an accelerated timeline and is precisely tailored to each person’s brain connectivity.

>>  Magnus Medical, Inc. Press Release

For more information:

Image

Encore Presentation
So Stimulating! Non-pharmacotherapy for Depression
CME/CE credits: 0.75  |  Expires: November 8, 2023

Image

Encore Presentation
Not Good Enough: What to Do When Standard Treatment for Depression Fails
CME/CE credits: 1.0  |  Expires: November 7, 2024

Image

Stahl's Essential Videos
Stahl’s Essential Psychopharmacology, Chapter 07c: Unipolar Depression: Treatment Resistance and Future Treatments
CME/CE credits: 0.75   |   Expires: February 3, 2025

Image

NEI Podcast
Episode 122 - (CME) Advancements in Depression Treatment Through Awareness of Adjunctive Agents
CME/CE credits: 1.00  |  Expires: October 21, 2024

Image

Encore Presentation
Aiming for Recovery: Optimizing Treatment for Major Depressive Disorder
CME/CE credits: 1.25  |  Expires: April 24, 2025

Image

Encore Presentation
What's Shakin': Brain Stimulation Therapies for Psychiatric Disorders
CME/CE credits: 0.75  |  Expires: November 10, 2022

Image

Upcoming CME/CE Meeting
2022 NEI Congress
November 2-6   |   Colorado Springs, CO & Online